|
Plasma tumour DNA dynamics and circulating subclones patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel in a prospective biomarker trial (NCT03381326). |
| |
|
Consulting or Advisory Role - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen; Janssen; Novartis; Pfizer |
| |
|
Patents, Royalties, Other Intellectual Property - PCF_SELECT |
| |
|
Travel, Accommodations, Expenses - Sanofi |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Amgen; Astellas Oncology; AstraZeneca; Bayer; Eisai; Janssen; Merck; Recordati |
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; Bristol-Myers Squibb; Gilead Sciences; Ipsen; Janssen |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - Bayer; Janssen |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - Pfizer |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; AstraZeneca; Bristol-Myers Squibb; Pfizer |
Research Funding - Ipsen (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; ipsen; Janssen Oncology; Merck/Pfizer; MSD Oncology |
Other Relationship - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Merck/Pfizer; MSD |
| |
|
Consulting or Advisory Role - AstraZeneca; JJ Innovative Medicine; Lilly; MSD; Takeda |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; JJ Innovative Medicine; Merck; MSD; Pfizer; Takeda |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Patents, Royalties, Other Intellectual Property - PCF_SELECT |
| |
|
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; PharmaMar |
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Ipsen; Merck; Pfizer |
| |
|
Honoraria - Astellas Pharma; Janssen; Janssen (I) |
Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; AstraZeneca; Bayer; ESSA; Ferring; Janssen-Cilag; Medivation; Millennium; Novartis; Pfizer; Ventana Medical Systems; Veridex |
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Ipsen; Janssen; Sanofi; Takeda; Ventana Medical Systems |
Research Funding - Astellas Pharma (Inst); Janssen (Inst) |
Patents, Royalties, Other Intellectual Property - I am on The ICR rewards to inventors list of abiraterone acetate. |
Travel, Accommodations, Expenses - Abbott Laboratories; Astellas Pharma; Astellas Pharma (I); Bayer; ESSA; Ferring; Janssen; Janssen (I); Medivation; Pfizer; Ventana Medical Systems |
Other Relationship - Institute of Cancer Research |